Combination therapy for acute myocardial infarction

Journal of the American College of Cardiology

Volumn 34, Issue 7, 1999, Pages 1963-1965

  Keeley, Ellen C ^a   Weaver, W Douglas ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ANTICOAGULATION; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; EDITORIAL; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; PRIORITY JOURNAL; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; VENTRICULAR FUNCTION, LEFT;

EID: 0342632823     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00456-8     Document Type: Editorial

References (14)

1. Lieu T.A., Gurley R.J., Lundstrom R.J., et al. primary angioplasty and thrombolysis for acute myocardial infarction an evidence summary . J Am Coll Cardiol. 27:1996;737-750.
2. Simes R.J., Topol E.J., Holmes D.R., et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion importance of early and complete infarct artery reperfusion . Circulation. 91:1995;1923-1928.
3. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge . Circulation. 76:1987;142-154.
4. The effects of tissue plasminogen activator, streptokinase, or both, on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
5. Ohman E.M., Califf R.M., Topol E.J., et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
6. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of acute primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction a quantitative view . JAMA. 278:1997;2093-2098.
7. Zijlstra F., Van de Boer M., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
8. Ross A.M., Coyne K.S., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction the PACT trial . J Am Coll Cardiol. 34:1999;1954-1962.
9. O'Neill W., Weintraub R., Grines C.L., et al. A prospective, placebo-controlled, randomized clinical trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 86:1992;1710-1717.
10. Lambert F.M., Merkhof V.D., Zijlstra F., et al. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty results of the Glycoprotein Receptor Antagonist Patency evaluation (GRAPE) pilot study . J Am Coll Cardiol. 33:1999;1528-1532.
11. Brener S.J., Barr L.A., Burchenal J.E., et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.
12. Lefkovits J., Ivanhoe R.J., Califf R.M., et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneoustransluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 77:1996;1045-1051.
13. Antman E.M., Giugliano R.P., Gibson C.M., et al. Abciximab facilitates the rate and the extent of thrombolysis results of the thrombolysis in myocardial infarction (TIMI) 14 trial . Circulation. 99:1999;2720-2732.
14. Ohman EM. Results of the SPEED (Strategies for Patency Enhancement in the Emergency Department) study. Presented at the 47th Scientific Session of the American College of Cardiology, Atlanta, March 1998.